Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
AIDS Malignancy Consortium
National Cancer Institute (NCI)
AIDS Malignancy Consortium
AIDS Malignancy Consortium
National Institute of Allergy and Infectious Diseases (NIAID)
AIDS Malignancy Consortium
AIDS Malignancy Consortium
Jonsson Comprehensive Cancer Center
AIDS Malignancy Consortium
Antiva Biosciences
Centre hospitalier de l'Université de Montréal (CHUM)
Antiva Biosciences
ANRS, Emerging Infectious Diseases
Southern California Institute for Research and Education